Claudia Vollbracht Selected Research

Claudia Vollbracht Research Topics

4	Fatigue 01/2022 - 11/2011
2	Pain (Aches) 01/2022 - 04/2012
2	Post-Acute COVID-19 Syndrome 01/2022 - 03/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 04/2012
2	Neoplasms (Cancer) 06/2021 - 05/2011
2	Sleep Wake Disorders 09/2018 - 11/2011
1	Thrombosis (Thrombus) 01/2022
1	COVID-19 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Cognitive Dysfunction 01/2022
1	Sepsis (Septicemia) 07/2021
1	Glioblastoma (Glioblastoma Multiforme) 06/2021
1	Hypersensitivity (Allergy) 09/2018
1	Herpes Zoster 04/2012
1	Infections 04/2012
1	Postherpetic Neuralgia 04/2012
1	Breast Neoplasms (Breast Cancer) 11/2011
1	Ascorbic Acid Deficiency (Vitamin C Deficiency) 11/2011
1	Nausea 11/2011
1	Dizziness (Lightheadedness) 11/2011
1	Disease Susceptibility (Diathesis) 11/2011
1	Carcinoma (Carcinomatosis) 05/2011

7	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022 - 05/2011
2	MicronutrientsIBA 07/2021 - 04/2012
1	AntioxidantsIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2021
1	CytokinesIBA 07/2021
1	Thiamine (Aneurin)FDA Link 07/2021
1	Therapeutic UsesIBA 07/2021
1	LipopolysaccharidesIBA 07/2021
1	Temozolomide (Temodar)FDA LinkGeneric 06/2021
1	Biological ProductsIBA 06/2021
1	Antineoplastic Agents (Antineoplastics)IBA 05/2011
1	Fluorouracil (Carac)FDA LinkGeneric 05/2011
1	Pharmaceutical PreparationsIBA 05/2011
1	SolutionsIBA 05/2011
1	Docetaxel (Taxotere)FDA Link 05/2011
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2011
1	Epirubicin (Ellence)FDA LinkGeneric 05/2011
1	Cytostatic AgentsIBA 05/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2011

3	Therapeutics 07/2021 - 11/2011
1	Critical Care (Surgical Intensive Care) 07/2021
1	Radiotherapy 11/2011